Key facts
- This page summarizes AVANOS MEDICAL, INC.'s Form 3 filing for AVANOS MEDICAL, INC. (AVNS).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 03 Jul 2024, 14:54.
AVANOS MEDICAL, INC. - 01 Jul 2024 Form 3 Insider Report for AVANOS MEDICAL, INC. (AVNS)
- Reporting relationship
- Director
- Issuer ticker
- AVNS
- Reported as of
- 01 Jul 2024
- Net transaction value
- $0
- Reporting owner signature
- /s/ Mojirade James, attorney-in-fact for Indrani Franchini pursuant to power of attorney filed herewith.
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
AVANOS MEDICAL, INC. filed Form 3 for AVANOS MEDICAL, INC. (AVNS) on 03 Jul 2024.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AVNS
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 4,817
- Date
- 01 Jul 2024
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Represents restricted share units (RSUs) issued to the Reporting Person on July 1, 2024 pursuant to the Avanos Medical, Inc. Outside Directors' Compensation Plan. Each RSU is the economic eqiuvalent of one share of Common Stock.